secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0001104659-24-120650
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics updates corporate presentation at Stifel Healthcare Conference
-------------------------------------------------------------------------

- Presentation highlights Eversense 365 CGM system FDA clearance and commercial launch.
- Collaboration with Mercy Health targeting up to 30,000 patients initiated Q3 2024, expansion expected 2025.
- Gemini (self-powered) and Freedom (no transmitter) development programs progressing with IDE filing planned 2025.
- CGM market opportunity described as $20B+ US TAM with ~21% CAGR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/0001104659-24-120650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/tm2428905d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-120650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer